We are live on ! Find out more
Royce & Associates

Royce & Associates Portfolio holdings

AUM $12.4B Turnover 20.64%
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$33.9B
AUM Growth
-$1.05B
Cap. Flow
-$1.27B
Cap. Flow %
-3.76%
Top 10 Hldgs %
9.76%
Holding
1,528
New
93
Increased
461
Reduced
505
Closed
116
Avg Time Held
0.7 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.5 years

Top Buys

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$50.1M
2
GCO icon
Genesco
GCO
+$46.4M
3
DAN icon
Dana Inc
DAN
+$41.3M
4
KW icon
Kennedy-Wilson Holdings
KW
+$31.1M
5
JBTM icon
JBT Marel
JBTM
+$30.8M

Sector Composition

Rank Sector Weight
1 Industrials 24.41%
2 Technology 17.65%
3 Consumer Discretionary 14.64%
4 Financials 10.23%
5 Materials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HCSG icon
301
Healthcare Services Group
HCSG
$1.45B
$26.9M 0.08%
925,839
+107,200
+13% +$2.94M
2013 Q2
3 quarters
ICFI icon
302
ICF International
ICFI
$1.6B
$26.8M 0.08%
672,450
+91,800
+16% +$3.36M
2013 Q2
3 quarters
KELYA icon
303
Kelly Services Class A
KELYA
$526M
$26.6M 0.08%
1,121,500
-17,000
-1% -$414K
2013 Q2
3 quarters
ULH icon
304
Universal Logistics Holdings
ULH
$430M
$26.4M 0.08%
914,900
-71,344
-7% -$2.04M
2013 Q2
3 quarters
EHC icon
305
Encompass Health
EHC
$12.6B
$26.4M 0.08%
923,644
-48,646
-5% -$1.27M
2013 Q2
3 quarters
DTSI
306
DELISTED
DTS, Inc.
DTSI
$26.2M 0.08%
1,327,729
– –
2013 Q2
3 quarters
CMP icon
307
Compass Minerals
CMP
$934M
$26M 0.08%
314,826
+53,000
+20% +$4.38M
2013 Q2
3 quarters
RTI
308
DELISTED
RTI INTL METALS INC(HLDG CO)
RTI
$25.9M 0.08%
933,813
+255,213
+38% +$7.58M
2013 Q2
3 quarters
MTOR
309
DELISTED
MERITOR, Inc.
MTOR
$25.9M 0.08%
2,116,921
-293,652
-12% -$3.3M
2013 Q2
3 quarters
MMSI icon
310
Merit Medical Systems
MMSI
$5.33B
$25.9M 0.08%
1,809,406
+65,500
+4% +$973K
2013 Q2
3 quarters
BR icon
311
Broadridge
BR
$19.8B
$25.8M 0.08%
693,800
-2,300
-0.3% -$86.2K
2013 Q2
3 quarters
AIN icon
312
Albany International
AIN
$1.72B
$25.7M 0.08%
723,581
+199,581
+38% +$7.12M
2013 Q2
3 quarters
TIVO
313
DELISTED
Tivo Inc
TIVO
$25.4M 0.07%
1,113,384
+1,086,384
+4,024% +$24.9M
2013 Q2
3 quarters
IVC
314
DELISTED
Invacare Corporation
IVC
$25.3M 0.07%
1,329,161
-126,600
-9% -$2.6M
2013 Q2
3 quarters
PRA icon
315
DELISTED
ProAssurance
PRA
$25.1M 0.07%
563,698
-50,000
-8% -$2.28M
2013 Q2
3 quarters
SLCA icon
316
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$25.1M 0.07%
656,500
+152,000
+30% +$4.9M
2013 Q2
3 quarters
AMRI
317
DELISTED
Albany Molecular Research Inc
AMRI
$25M 0.07%
1,344,610
-67,958
-5% -$936K
2013 Q2
3 quarters
IPHS
318
DELISTED
Innophos Holdings, Inc.
IPHS
$24.9M 0.07%
438,781
-380,702
-46% -$19.5M
2013 Q2
3 quarters
HWCC
319
DELISTED
Houston Wire & Cable Company
HWCC
$24.9M 0.07%
1,892,800
+42,952
+2% +$573K
2013 Q2
3 quarters
TR icon
320
Tootsie Roll Industries
TR
$2.87B
$24.7M 0.07%
1,176,860
-44,058
-4% -$914K
2013 Q2
3 quarters
ARCB icon
321
ArcBest
ARCB
$2.91B
$24.7M 0.07%
667,420
+21,200
+3% +$723K
2013 Q2
3 quarters
CEB
322
DELISTED
CEB Inc.
CEB
$24.6M 0.07%
331,600
-306,900
-48% -$23M
2013 Q2
3 quarters
PRXL
323
DELISTED
Parexel International Corp
PRXL
$24.6M 0.07%
455,000
– –
2013 Q2
3 quarters
TKR icon
324
Timken Company
TKR
$7.79B
$24.6M 0.07%
584,540
-13,690
-2% -$563K
2013 Q2
3 quarters
MTD icon
325
Mettler-Toledo International
MTD
$32.5B
$24.6M 0.07%
104,300
-22,500
-18% -$5.51M
2013 Q2
3 quarters

Similar funds

Royce & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Royce & Associates held 1,528 positions worth $33.9B, down 3% from $34.9B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Royce & Associates withdrew a net $1.27B in Q1 2014, closing 116 positions and reducing 505 holdings. Its most notable exit was ARDEN GROUP INC CL-A, an estimated $34.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Neenah, Inc. Common Stock worth $23.5M.

  • Royce & Associates's largest Q1 2014 buy was Neenah, Inc. Common Stock: 454,500 shares worth $23.5M.
  • Royce & Associates added most to Medicines Co in Q1 2014, an estimated $50.1M increase.
  • Royce & Associates's biggest Q1 2014 reduction was TOWERS WATSON & CO COM STK CL A (DE), cutting an estimated $87.3M.
  • Royce & Associates fully exited ARDEN GROUP INC CL-A in Q1 2014, selling an estimated $34.3M.
  • Royce & Associates's ten largest holdings make up 9.8% of its $33.9B portfolio in Q1 2014.
  • Royce & Associates opened 93 new positions and closed 116 in Q1 2014.
  • Royce & Associates's portfolio value fell 3% quarter-over-quarter to $33.9B.

Based on Royce & Associates's 13F filing for Q1 2014, filed 12 May 2014.